Inserm, U-1003, Equipe labellisée par la Ligue Nationale contre le cancer, Villeneuve d'Ascq, France.
J Physiol. 2012 Mar 15;590(6):1369-76. doi: 10.1113/jphysiol.2011.225862. Epub 2012 Feb 13.
Abstract The TRPV6 channel belongs to the superfamily of transient receptor potential (TRP) channels, subfamily vanilloid, member 6. Its expression in health is mainly confined to epithelial tissue of different organs such as digestive tract, kidney, testis, ovaries and skin. Due to its high calcium selectivity over other TRP channels, this channel was shown to participate in close regulation of calcium homeostasis in the body. In cancer a number of pieces of evidence demonstrate its upregulation and correlation with the advanced stages in prostate, colon, breast, thyroid, and ovarian carcinomas. Little is known about its role in initiation or progression for most of cancers, though in prostate cancer its oncogenic potential in vitro has been suggested. The most probable mechanisms involve calcium signalling in the control of processes such as proliferation and apoptosis resistance, though in some cases first evidence was reported as to its likely protective role in some cancers such as colon cancer. Further studies are needed to confirm whether this channel does really have an oncogenic potential or is just the last hope for transformed cells/tissues to stop cancer.
摘要 TRPV6 通道属于瞬时受体电位 (TRP) 通道超家族的香草素亚家族成员 6。其在健康状态下的表达主要局限于消化道、肾脏、睾丸、卵巢和皮肤等不同器官的上皮组织。由于其对其他 TRP 通道具有较高的钙离子选择性,该通道被证明参与了体内钙稳态的密切调节。在癌症中,有大量证据表明它在前列腺癌、结肠癌、乳腺癌、甲状腺癌和卵巢癌的晚期表达上调,并与这些癌症相关。尽管在体外研究中提示 TRPV6 通道在前列腺癌中具有致癌潜能,但对于大多数癌症,其在起始或进展中的作用知之甚少。最可能的机制涉及钙信号在控制增殖和抗凋亡等过程中的作用,尽管在某些情况下,首次有证据表明其在某些癌症(如结肠癌)中可能具有保护作用。需要进一步的研究来证实该通道是否真的具有致癌潜能,或者它是否只是转化细胞/组织阻止癌症的最后希望。